Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
36.67
+1.20 (3.38%)
At close: Aug 13, 2025, 4:00 PM
36.87
+0.20 (0.55%)
Pre-market: Aug 14, 2025, 8:39 AM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $2.11 billion as of August 14, 2025. Its market cap has increased by 9.52% in one year.
Market Cap
2.11B
Enterprise Value
1.72B
1-Year Change
9.52%
Ranking
Category
Stock Price
$36.67
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.11B, an increase of 357.61%. That is a compound annual growth rate of 35.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.04B | 3.99% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 586.68B |
| Johnson & Johnson | 417.87B |
| AbbVie | 348.95B |
| UnitedHealth Group | 231.12B |
| AstraZeneca | 227.85B |
| Abbott Laboratories | 227.74B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |